March 1st, 2012 - (IFPMA) - Healthcare Regulatory update

The global pharmaceutical industry is tightening its code of practice in a bid to stamp out bribery and corruption, particularly in emerging markets.

The 2012 IFPMA code revision extends the rules covering drug company behavior to also include interactions with medical institutions and patient organizations, as well as healthcare professionals, such as prescribing doctors.

http://www.ifpma.org/fileadmin/content/Publication/IFPMA_Code_of_Practice_2012.pdf